Cell 2026
.png)
12 - 13 November 2026
Novotel London West, UK
Novotel London West, UK
.png "Live Now Button (3)")
Alison Caldwell
CMC Regulatory Affairs Manager,
Resolution Therapeutics
Amelia Lane
Director of Preclinical Development,
MeiraGTx
Amy Sanders
Research Scientist,
AstraZeneca
Antonio Salgado
Vice-Dean of Research,
uminho
Ben Weil
Chief Operating Officer/Chief Manufacturing Officer,
INmune Bio
Bernd Schmidt
Chief Technical Officer,
Sensorion
Bo Wiinberg
Chief Business Development Officer,
Novo Nordisk Foundation Cellerator
Claudio Mussolino
Group Leader,
Medical Center - University of Freiburg
Helene Boland
Senior Associate Global Regulatory,
Hogan Lovells
Hollie Bartley
Director PD,
Resolution Therapeutics
Ilya Yasny
Partner,
LanceBio Ventures
Jacqueline Barry
Chief Clinical Officer,
Cell and Gene Therapy Catapult
Jerry wu
Managing Director,
LongRiver Investments
John Bridgeman
CSO,
ImmunoKey Ltd
Jose Meseguer
Group Lead - Translational Data Science,
Resolution-Tx
Josh Bagley
Chief Scientific Officer,
AheadBio
Kerry Hallbrook
Associate Principal Scientist,
AstraZeneca
Killian Hanlon
CEO + Chief Scientist,
Lir Therapeutics
Kristian Tryggvason
Chief Executive Officer,
Alder Therapeutics
Lara Campana
SVP, Head of Research and Translational Science,
Resolution Therapeutics Ltd
Leila Abbas
Preclinical Lead,
Rinri Therapeutics
Lilian Hook
Director Cell, Apheresis and Gene Therapies,
NHSBT
Lindsay Davies,
Chief Executive Officer,
NextCell Pharma AB
Luke Lindsay-Hill
Senior Scientist,
MHRA
Manel Juan
Group Leader,
EMEUNET - the Emerging Eular NETwork
Marcelo Rivolta
Chief Scientific Officer,
Rinri Therapeutics
Marina Tarunina
Research Director,
Plasticell
Mark Eccleston
Chief Executive Officer,
ValiRx
Mark Piskadlo
Vice President, Cell Therapy Manufacturing,
Bristol Myers Squibb
Melissa Barr
Head Of Scientific Operations,
Inaphaea BioLabs
Michael MacDonald
Senior Process Development Scientist,
AviadoBio
Nicolas Szita
Professor,
UCL
Nicole Lund
Senior Director,
BlueRock Therapeutics
Peter Andersen
Chief R&D Officer,
TreeFrog Therapeutics
Raphael Ognar
President & CEO, Co-founder,
NKILT Therapeutics, Inc.
Rebecca Moore
Director of Analytical Development and Quality Control,
Quell
Reinhold Medina
Professor,
Queen's University Belfast
Roelof Rongen
Co-Founder & Board Director,
AeirBio, Inc.
Romina Vuono
Principal Investigator and Lecturer, Neuroscience,
University of Kent
Ruben Rizzi
SVP Global Regulatory Affairs,
BioNTech SE
Seema Bansal, Ph. D
Scientific Director, Cell Therapy Analytical Development, CTD,
Novartis Pharma
Simon Walker
Head of MSAT,
GTVF KCL
Stephan Krause
Executive Director for Cell Therapies,
BMS
Stijn Heessen Heessen
Chief Operating Officer,
Alder Therapeutics
Ulrich Rümenapp
Senior Lead,
Bayer AG
Victor Hernandez
Co-founder and Chief Scientific Officer,
Axovia Therapeutics
William Alex Smith
Director,
Hogan Lovells LLP
Xiaohua Wang
Sr. Director, Integrative Science/ New Modality, Cell Therapy, IO & ICV,
Bristol Myers Squibb
Our Esteemed Sponsors for Cell 2026
Gold Sponsors
Silver Sponsors
Novo Nordisk Pharmatech
Silver Sponsor
At Novo Nordisk Pharmatech, we are committed to developing life science solutions that enable medicines for our customers sustainably. We are proud that our innovative research and products help millions of people around the world live better lives. We provide products to aid pharmaceutical manufacturing in four product areas: Recombinant Insulin, Recombinant Enzymes, Resins, and Benzalkonium Chloride. We will continue strengthening our partnerships with those customers needing animal-free and reliable cGMP manufactured ingredients supplied securely and consistently. Quality is our top priority, and we always ensure high batch-to-batch consistency and full documnetation packages across according to current regulations and standards.
-243c71.png?length=600&name=f23c7184-91b0-4f6d-8596-230bd31a487f-2-5668375logo-download-logo-png-data-(2)-243c71.png){kind=logo}
Sartorius Stedim Biotech GmbH
Silver Sponsor
Sartorius is a leading global partner of the biopharmaceutical industry dedicated to enabling cell and gene therapy developers to manufacture and commercialize their advanced therapy medicinal products (ATMPs). Over the last decade the company has expanded its legacy portfolio of single-use bioprocessing solutions through the acquisition of complementary advanced therapy consumables, services, and technologies—from plasmid engineering and manufacturing to cell culture media, reagents and monolithic chromatography. Sartorius’ advanced therapy solutions are designed to overcome current ATMP production challenges by enhancing productivity, improving process economics, and supporting safe and regulatory compliant manufacturing. Sartorius products are currently used in approved cell and gene therapies and actively support clinical pipelines worldwide. The company’s continued investment in innovative solutions demonstrates their commitment to advancing the field and making access to these life-saving treatments a reality.
Bronze Sponsors
Network & Programme Sponsors
Eppendorf
Presentation & Exhibition
Eppendorf - You have a vision. We have a mission.
At Eppendorf, our aim is to empower you on your upstream bioprocess journey. We provide trusted and innovative bioprocess solutions to develop cell culture and fermentation bioprocesses and move them from R&D to production. We have orchestrated our scalable bioprocess systems, single-use bioreactors, software solutions, and services to optimize process control, automate routine tasks, and harness the power of data. We listen to your specific challenges and work together with you to solve them. The bottom line is more speed, less risk, and more success in your business.
Our purpose is to help bring life-saving treatments to the world. With our bioprocess solutions and in line with our corporate mission, we contribute to the efforts of Eppendorf customers worldwide to improve human living conditions.
Since 1945, the Eppendorf Group has been headquartered in Hamburg, Germany, and today operates production and R&D sites in Europe, Asia and North America and has subsidiaries in 33 countries. Today, the Group employs more than 5,000 people worldwide.
Start-Ups
.jpg?width=2819&height=1174&name=74dfee8e-75c7-46e0-9f51-31b709af2ede-2-5668375logo-Nanion_logo_black_RGB_300dpi-(2).jpg){kind=logo}
